Gemtuzumab Ozogamicin as First-Line Treatment in Patients Aged 70 Years or Older With Acute Myeloid Leukemia Article

cited authors

  • McHayleh, Wassim; Foon, Kenneth; Redner, Robert; Sehgal, Rajesh; Raptis, Anastasios; Agha, Mounzer; Luong, Minh; Schlesselman, James J.; Boyiadzis, Michael

authors

Publication Date

  • June 15, 2010

webpage

published in

category

keywords

  • acute myeloid leukemia
  • gemtuzumab ozogamicin
  • prognostic factors
  • therapy

start page

  • 3001

end page

  • 3005

volume

  • 116

issue

  • 12